Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT04342429
Status
Recruiting
Apply to this trial

Conditions

  • Small-cell Lung Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Proton-beam Therapy for Small Cell Lung Cancer — RADIATION
    The goal of intensity-modulated proton therapy (IMPT) is to deliver radiation to the tumor while minimizing exposure to surrounding normal tissues.

Study Details

To assess the safety and efficacy of intensity-modulated proton therapy (IMPT) for small cell lung cancer (SCLC)

Key Dates

Start date
Mar 19, 2020
Status verified
Jul 2025
Primary completion
May 27, 2026
Completion
May 27, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Prospective Study of Intensity-Modulated Proton Therapy (IMPT)
    This is the first prospective study to investigate the safety and efficacy of IMPT for the treatment of SCLC. We will utilize adaptive planning throughout the radiation course. In addition, we will study the dosimetric parameters of IMPT and their correlation with treatment-related toxicities, particularly cardiac events.

Primary Outcome Measure

Patients with small cell lung cancer (SCLC) will be assessed with the intensity-modulated proton therapy (IMPT). [ Time Frame: Up to 1 year from study start ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Winship Cancer InstituteAtlantaGeorgia30322
Kristin Higgins, MD
[email protected]
404-778-0603
Allyson Anderson
[email protected]
404-251-2854

Find similar trials in Atlanta, GA

By research site
Winship Cancer Institute· Atlanta, GA

Related Studies